Anaplastic large cell lymphoma medical therapy

	Anaplastic large cell lymphoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Anaplastic large cell lymphoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Anaplastic large cell lymphoma medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Anaplastic large cell lymphoma medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Anaplastic large cell lymphoma medical therapy
CDC on Anaplastic large cell lymphoma medical therapy
Anaplastic large cell lymphoma medical therapy in the news
Blogs on Anaplastic large cell lymphoma medical therapy
Directions to Hospitals Treating Anaplastic large cell lymphoma
Risk calculators and risk factors for Anaplastic large cell lymphoma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2], Kamal Akbar, M.D.[3]; Grammar Reviewer: Natalie Harpenau, B.S.[4]

Overview[edit | edit source]

The predominant therapy for anaplastic lymphoma is chemotherapy. Adjunctive radiotherapy, stem cell transplantation, and surgery may be required. The optimal therapy for anaplastic large cell lymphoma depends on the type and extent of anaplastic large cell lymphoma.

Medical Therapy[edit | edit source]

The optimal therapy for anaplastic large cell lymphoma depends on:

Type of anaplastic large cell lymphoma
Extent of anaplastic large cell lymphoma

**Treatment for anaplastic large cell lymphoma**
Type	Chemotherapy	Radiotherapy	Stem cell transplant	Surgery
Primary cutaneous anaplastic large cell lymphoma	Only used for people with extensive disease, where many areas of the skin are affected Used for people cannot be treated with localized treatment	External beam radiation therapy to the area (for localized disease)	--------	Surgery to remove the affected skin
Primary systemic anaplastic large cell lymphoma	Drug Regimen: (CHOP) Cyclophosphamide AND Doxorubicin AND Vincristine AND Prednisone	May be offered	May be offered	--------

Chemotherapy[edit | edit source]

Anaplastic large cell lymphoma usually responds well to chemotherapy, so it often has a good prognosis.
Anaplastic large cell lymphoma is treated with the same combinations of chemotherapy drugs used to treat other aggressive lymphomas.
Drug Regimen: (CHOP) Cyclophosphamide AND Doxorubicin AND Vincristine AND Prednisone^[1]

Radiation therapy[edit | edit source]

Radiation therapy is most often given after chemotherapy.^[2]

External beam radiation therapy may be used:

When the lymphoma cells are only in one area of the lymph nodes (stage I primary systemic anaplastic large cell lymphoma).
For localized skin lesions in primary cutaneous anaplastic large cell lymphoma.

Stem cell transplant[edit | edit source]

A stem cell transplant may be offered to patients with anaplastic large cell lymphoma who relapse after initial treatment.^[3]

References[edit | edit source]

↑ Vu K, Ai W (2018). "Update on the Treatment of Anaplastic Large Cell Lymphoma". Curr Hematol Malig Rep. 13 (2): 135–141. doi:10.1007/s11899-018-0436-z. PMID 29516333.
↑ Julie, D.A.; Mann, J.M.; Wu, X.; Nagar, H. (2017). "Role of Adjuvant Radiotherapy for Early-Stage Anaplastic Large Cell Lymphoma: Analysis of the National Cancer Database". International Journal of Radiation Oncology*Biology*Physics. 99 (2): S141. doi:10.1016/j.ijrobp.2017.06.327. ISSN 0360-3016.
↑ Deconinck E, Lamy T, Foussard C, Gaillard F, Delwail V, Colombat P; et al. (2000). "Autologous stem cell transplantation for anaplastic large-cell lymphomas: results of a prospective trial". Br J Haematol. 109 (4): 736–42. PMID 10929023.

Template:WH Template:WS

[pmid29516333-1] Vu K, Ai W (2018). "Update on the Treatment of Anaplastic Large Cell Lymphoma". Curr Hematol Malig Rep. 13 (2): 135–141. doi:10.1007/s11899-018-0436-z. PMID 29516333.

[JulieMann2017-2] Julie, D.A.; Mann, J.M.; Wu, X.; Nagar, H. (2017). "Role of Adjuvant Radiotherapy for Early-Stage Anaplastic Large Cell Lymphoma: Analysis of the National Cancer Database". International Journal of Radiation Oncology*Biology*Physics. 99 (2): S141. doi:10.1016/j.ijrobp.2017.06.327. ISSN 0360-3016.

[pmid10929023-3] Deconinck E, Lamy T, Foussard C, Gaillard F, Delwail V, Colombat P; et al. (2000). "Autologous stem cell transplantation for anaplastic large-cell lymphomas: results of a prospective trial". Br J Haematol. 109 (4): 736–42. PMID 10929023.

[1]

[2]

[3]